TransMedics Group Inc (TMDX)

Return on assets (ROA)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 35,464 32,638 3,000 -10,195 -25,028 -35,779 -17,783 -28,305 -36,231 -42,179 -47,715 -46,860 -44,215 -37,858 -29,984 -27,813 -28,748 -31,614 -34,806 -35,504
Total assets US$ in thousands 804,076 785,571 758,577 723,831 706,047 689,227 690,358 287,088 277,147 274,873 117,285 124,008 134,893 131,146 140,512 145,783 152,026 159,322 163,137 96,923
ROA 4.41% 4.15% 0.40% -1.41% -3.54% -5.19% -2.58% -9.86% -13.07% -15.34% -40.68% -37.79% -32.78% -28.87% -21.34% -19.08% -18.91% -19.84% -21.34% -36.63%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $35,464K ÷ $804,076K
= 4.41%

TransMedics Group Inc's return on assets (ROA) experienced a significant improvement over the period from March 31, 2022 to December 31, 2024. The ROA started at a low of -37.79% in March 31, 2022 and steadily increased to reach positive territory, with a ROA of 4.41% by the end of December 31, 2024. This positive trend indicates that the company's assets have been utilized more efficiently to generate profits during this period. The improvement in ROA suggests that TransMedics Group Inc has been able to enhance its operational efficiency and profitability, which bodes well for the company's financial performance and overall strength.